In the recently published ‘A 3D printed microfluidic-enabled hollow microneedle architecture for transdermal drug delivery,’ researchers explore innovative methods for delivering medication into the bloodstream via the skin. In this study, they work on the micro-level to create ‘new degrees of freedom’ in delivery.
As medicine continues in the direction of patient-specific treatments, 3D printing continues to play an enormous role—including medical devices, implants, innovations in tissue engineering like scaffolding, and much more. In this study, the researchers continue to refine the use of needles for transdermal use.
Conventionally, they have been fabricated with materials like plastics, metals, ceramics, and more. With the advent of biocompatible polymers, microneedles are being more widely used due to greater disposability, affordability, and the potential for customization—pointing toward patient-specific benefits overall.
Microfluidic devices are behind many of the new capabilities in drug delivery systems, allowing for mixing and transporting of the required small amounts of fluids.
“For example, microfluidic mixing was used to directly synthesize nanoparticles with tunable physicochemical properties such as particle size, homogeneity, and drug loading and release at the point of delivery,” state the researchers. “Additionally, the combination of microneedles and microfluidic mixing is beneficial in areas such as combinational therapy-based subcutaneous/transdermal administration for preclinical testing of biologic treatments.”
New systems are being developed too for ‘codosing,’ allowing for patients to receive several medications at once. Microfluidics and innovative drug delivery systems make the process more affordable, simpler, and less open to error. This study yields microfluidic-enabled microneedle devices printed via single-step stereolithography (SLA) from an ‘elaborate hollow microneedle design,’ resulting in a refined microneedle array.
“This architecture allows the modulation of the input fluid solutions’ flow rates to facilitate programmable drug delivery in future combinational therapy-based applications,” stated the researchers.
While there are benefits to SLA 3D printing, the research team was tasked to refine the process further for this study, creating a new microneedle design and print set up.
The research team was able to create up to 12 devices (with dimensions of 1.5 × 1.2 × 3.1 cm) using class IIa biocompatible resin in a single print, in 2.5 hours.
Scanning microscopy displayed success in both design and 3D printing of the arrays.
“Penetration and fracture tests confirmed the microneedles’ mechanical robustness for practical application. An example microfluidic-enabled microneedle device was printed with our devised scheme that facilitates homogeneous mixing of multiple fluids under different flow rates, followed by transdermal delivery of the mixed solution. Comparisons of various flow rate ratios with colored dye solutions showed tunable control over the relative concentrations of solutes delivered. Ex vivo confocal laser scanning microscopy of three fluorochrome model-drug solutions on porcine skin further validated the platform’s ability for transdermal drug modulation and delivery,” concluded the researchers.
“This 3D printed device is particularly applicable to preclinical investigations centered on combinational drug therapy, where the in-situ combination of multiple drugs and the tuning of their physicochemical properties lead to more effective outcomes than single or premixed agents alone. For example, the controlled multifluidic synthesis of nanoparticles can tune the release mechanisms of various drugs for wound healing applications.”
What do you think of this news? Let us know your thoughts! Join the discussion of this and other 3D printing topics at 3DPrintBoard.com.[Source / Images: ‘A 3D printed microfluidic-enabled hollow microneedle architecture for transdermal drug delivery’]
You May Also Like
Dymex and Mechnano Use Carbon Nanotube Technology for 3D Printing Materials
Just days after Arizona-based startup Mechnano presented a pioneering new way to use carbon nanotubes (CNTs) in additive manufacturing (AM) materials, the company announced it was also teaming up with...
AZO and AddUp Partner to Automate Powder Handling for Metal 3D Printing
Metal powders are some of the most finicky materials in the 3D printing industry in that, not only do the metal particles require a high level of consistency, sphericity, and...
AMUG 2021: PostProcess Technologies and Carbon Partner for Automated Resin Removal in 3D Printing
It has apparently become clear to 3D printer manufacturers that the post-processing firms are big enough now to integrate their finishing technologies can be more directly integrated into their ecosystems....
AMUG 2021: DyeMansion and Stratasys to Deliver Total Solution for 3D Printing and Finishing SAF Parts
As a new powder bed fusion process, Stratasys’s new selective absorption fusion (SAF) technology promises to deliver high-volume parts at attractive prices. Upon announcing its first SAF system alongside two...
View our broad assortment of in house and third party products.